ENTRY       D02740            Mixture   Drug
NAME        Lidocaine and prilocaine;
            Lidocaine and propitocaine;
            Emla (TN);
            Oraqix (TN);
            Lidocaine and prilocaine (TN)
PRODUCT     ORAQIX (Dentsply Pharmaceutical)
  GENERIC   LIDOCAINE AND PRILOCAINE (A-S Medication Solutions)
            LIDOCAINE AND PRILOCAINE (Actavis Pharma)
            LIDOCAINE AND PRILOCAINE (Akorn)
            LIDOCAINE AND PRILOCAINE (Alembic Pharmaceuticals)
            LIDOCAINE AND PRILOCAINE (Aleor Dermaceuticals Limited)
            LIDOCAINE AND PRILOCAINE (Amneal Pharmaceuticals of New York LLC)
            LIDOCAINE AND PRILOCAINE (Bryant Ranch Prepack)
            LIDOCAINE AND PRILOCAINE (E. Fougera & Co. a division of Fougera Pharmaceuticals)
            LIDOCAINE AND PRILOCAINE (Kesin Pharma Corporation)
            LIDOCAINE AND PRILOCAINE (NuCare Pharamceuticals)
            LIDOCAINE AND PRILOCAINE (Padagis US LLC)
            LIDOCAINE AND PRILOCAINE (Proficient Rx LP)
            LIDOCAINE AND PRILOCAINE (Rhodes Pharmaceuticals L.P.)
COMPONENT   Lidocaine [DR:D00358], Prilocaine [DR:D00553]
CLASS       Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1219
            ATC code: N01BB52 N01BB54
            Product: D02740<JP/US>
EFFICACY    Anesthetic (topical)
COMMENT     Lidocaine is primarily metabolized by CYP1A2 and CYP3A4.
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BB Amides
                 N01BB52 Lidocaine, combinations
                  D02740  Lidocaine and prilocaine &lt;JP/US&gt;
                 N01BB54 Prilocaine, combinations
                  D02740  Lidocaine and prilocaine &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anesthetics
              Local Anesthetics
               Lidocaine/ Prilocaine
                D02740  Lidocaine and prilocaine
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               121  Local anesthetics
                1219  Others
                 D02740  Lidocaine and prilocaine
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D02740  Lidocaine and prilocaine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D02740  Lidocaine and prilocaine
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02740
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02740
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02740
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D02740
DBLINKS     CAS: 101362-25-8
            PubChem: 47205816
///
